Are we expecting some positive reports soon, of recoveries in our eIND use and our Open Label Extension s/c Trial use of Leronlimab?

Would reports of these recoveries only be available to us in the form of a Cytodyn Press Release?

During the last Conference Call, Nader said "we have been smashed with eIND applications"...........